{
    "title": "113_s895",
    "content": "SECTION 1. SHORT TITLE.\n\n    This Act may be cited as the ``Antimicrobial Data Collection Act''.\n\nSEC. 2. RESEARCH PROGRAMS TO STUDY ANTIMICROBIAL RESISTANCE.\n\n    (a) Definitions.--In this Act--\n            (1) the term ``Commissioner'' means the Commissioner of \n        Food and Drugs; and\n            (2) the term ``Secretary'' means the Secretary of Health \n        and Human Services.\n    (b) Commencement of Pilot Data Collection and Analysis Program.--\nThe Secretary, acting through the Commissioner, shall develop a \nresearch program or programs to study the relationship between the \nsales, distribution, end-use practices of animal drugs containing an \nantimicrobial active ingredient in food-producing animals and \nantimicrobial resistance trends. The Secretary may also consider any \nother available sound information, science, research, expertise, or \nprogram designs in carrying out this subsection.\n    (c) Purpose of Programs.--Any research program developed under \nsubsection (b) shall be developed in order to better determine--\n            (1) the relationships between sales data, distribution \n        data, and end-usage data of animal drugs containing an \n        antimicrobial active ingredient in food-producing animals to \n        inform policies of Food and Drug Administration regarding data \n        collection and regulation of antimicrobial products in \n        agriculture, including consideration of the potential value and \n        feasibility of data from veterinary feed directives and other \n        sources; and\n            (2) the relationships between the use of animal drugs \n        containing an antimicrobial active ingredient in food-producing \n        animals and trends in antimicrobial resistance, including by \n        using the data collected through the National Antimicrobial \n        Resistance Monitoring System or other studies regarding \n        resistance levels in bacteria associated with food-producing \n        animals.\n    (d) Consultation.--Any research program developed under subsection \n(b) shall be developed in consultation with the Secretary of \nAgriculture, which shall include at a minimum consultation with the \nUnder Secretary for Food Safety, the Under Secretary for Marketing and \nRegulatory Programs, and the Under Secretary for Research, Education, \nand Economics at the Department of Agriculture. To the extent \npracticable, such Under Secretaries shall provide assistance in \ndeveloping and conducting such research programs.\n    (e) Implementation.--Not later than 180 days after the date of \nenactment of this Act, the Secretary shall implement the research \nprogram or programs developed under subsection (b). The Secretary shall \nanalyze data from such program or programs to determine the \ncontribution of such data to studying antimicrobial resistance and \nestablishing the antimicrobial data collection strategy as described in \nsection 3(b)(1)(B).\n\nSEC. 3. REPORTS TO CONGRESS; DEVELOPMENT OF DATA COLLECTION STRATEGY.\n\n    (a) Initial Report.--As soon as practicable after the date of \nenactment of this Act, the Secretary shall--\n            (1) submit to Congress a report that--\n                    (A) describes the research design and goals for the \n                research program or programs developed under section \n                2(b); and\n                    (B) includes a needs assessment, considering broad \n                sources of data and models on antimicrobial use in \n                food-producing animals that the Food and Drug \n                Administration may need or from which the Food and Drug \n                Administration could benefit, to improve the evaluation \n                of Food and Drug Administration programs regarding \n                antimicrobial resistance and how a systematic and valid \n                data collection strategy will be designed to comply \n                with subsection (b)(1)(B); and\n            (2) make such report publicly available.\n    (b) Report Regarding Results and Recommendations.--Not later than 2 \nyears after the date of enactment of this Act, the Secretary shall--\n            (1) submit to Congress a report that--\n                    (A) describes the comprehensive results of any \n                research program or programs developed under section \n                2(b), including with respect to the determinations made \n                pursuant to paragraphs (1) and (2) of section 2(c); and\n                    (B) provides recommendations for developing an \n                antimicrobial data collection strategy based on the \n                information contained in the comments to the Advanced \n                Notice of Proposed Rulemaking entitled ``Antimicrobial \n                Animal Drug Distribution Reporting'' (77 Fed. Reg. \n                44177 (July 27, 2012)) and any relevant information \n                obtained in the research pilot program carried out \n                under section 2; and\n            (2) make such report publicly available.\n\nSEC. 4. ENHANCED REPORTING AND PUBLICATION OF SALES DATA.\n\n    (a) In General.--Section 512(l)(3)(E) of the Federal Food, Drug, \nand Cosmetic Act (21 U.S.C. 360b(l)(3)(E)) is amended--\n            (1) by redesignating clauses (i) and (ii) as subclauses (I) \n        and (II);\n            (2) by striking ``The Secretary shall make summaries of the \n        information reported under this paragraph publicly available, \n        except that--'' and inserting ``(i) Not later than a date \n        established by the Secretary for 2014, and on such date in each \n        year thereafter, the Secretary shall make publicly available a \n        summary of the information (including dosage form information, \n        if practicable) reported under this paragraph for the previous \n        year, except that--''; and\n            (3) by inserting after subclause (II), as redesignated by \n        paragraph (1), the following:\n    ``(ii) In making the summaries available under this subparagraph, \nthe following shall apply:\n            ``(I) The Secretary shall segregate the categories of \n        amounts reported into the following 2 subcategories, after \n        consultation with applicable classifications as determined by \n        the Secretary, subject to subclause (IV):\n                    ``(aa) The volume of drugs of importance to human \n                medicine.\n                    ``(bb) The volume of drugs not of importance to \n                human medicine.\n            ``(II) As practicable, the Secretary shall segregate \n        amounts reported into the following:\n                    ``(aa) Container size.\n                    ``(bb) Strength.\n                    ``(cc) Dosage form.\n                    ``(dd) Marketing status.\n            ``(III) In any cross-tabulation of the amounts reported \n        with any reporting category, the Secretary shall include the \n        categories `Not Independently Reported' and `Not Independently \n        Reported Export'.\n            ``(IV) Every 5 years, the Secretary shall reevaluate the \n        classifications consulted under subclause (I) after opportunity \n        for public comment.\n    ``(iii) The Secretary shall maximize the quality, accuracy, detail, \nand specificity of data made publicly available in the summaries under \nthis subparagraph, to the extent practicable, such as regarding the \ntype, estimated level of exposure, and target animals of antimicrobial \ndrugs. In carrying out the preceding sentence, the Secretary may \nprovide additional information in such summaries.\n    ``(iv) The Secretary shall conduct an annual evaluation of the \neffectiveness of and compliance with relevant policies and programs of \nthe Food and Drug Administration regarding antimicrobial drug sales for \nfood-producing animals, and use of such drugs and antimicrobial \nresistance, using valid and robust performance metrics. Beginning in \n2014, the Secretary shall include with each annual summary made \npublicly available under this subparagraph a report that describes the \nresults of the evaluation conducted under this clause with respect to \nthe preceding year.''.\n    (b) Reissuance.--Not later than 3 years after the date of enactment \nof this Act, the Secretary shall reissue the summary reports issued \nbefore 2012 under section 512(l)(3)(E) of the Federal Food, Drug, and \nCosmetic Act (21 U.S.C. 360b(l)(3)(E)) using the format designed for \nthe 2012 summary report. The Secretary shall publish the reissued \nreports in one combined publication.\n\nSEC. 5. ACTION TO PROTECT PUBLIC AND ANIMAL HEALTH.\n\n    (a) Publication of Final Guidance.--\n            (1) In general.--Not later than 180 days after the date of \n        enactment of this Act, the Secretary shall publish a final \n        version of the draft Voluntary Guidance #213 of the Food and \n        Drug Administration (entitled ``New Animal Drugs and New Animal \n        Drug Combination Products Administered in or on Medicated Feed \n        or Drinking Water of Food-Producing Animals: Recommendations \n        for Drug Sponsors for Voluntarily Aligning Product Use \n        Conditions with GFI #209'').\n            (2) Effect of subsection.--Nothing in this subsection shall \n        be construed to affect any other obligations of the Food and \n        Drug Administration regarding the authorities of such \n        Administration to regulate antimicrobial drugs and protect \n        public health.\n    (b) Report by GAO.--\n            (1) In general.--Not later than 3 years after the \n        conclusion of the research pilot program or programs developed \n        under section 2, the Comptroller General of the United States \n        shall commence a study to evaluate--\n                    (A) the approaches used by the Food and Drug \n                Administration to eliminate injudicious use of \n                antimicrobial drugs in food-producing animals; and\n                    (B) the effectiveness of the data collection \n                activities carried out by the Food and Drug \n                Administration regarding antimicrobial resistance.\n            (2) Report.--Not later than 1 year after commencing the \n        study described in paragraph (1), the Comptroller General of \n        the United States shall submit to the Committee on Health, \n        Education, Labor, and Pensions of the Senate and the Committee \n        on Energy and Commerce of the House of Representatives a report \n        that describes the results of such study."
}